Actively Recruiting
Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery
Led by University of Novi Sad · Updated on 2024-12-04
200
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, randomized, single blinded, controlled clinical trial designed to compare the clinical effects of sedation with dexmedetomidine versus propofol in patients undergoing cardiac surgery.
CONDITIONS
Official Title
Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing open heart surgery with the use of cardiopulmonary bypass (including coronary artery bypass grafting, valve repair/replacement, and combined)
- Left ventricular ejection fraction (LVEF) greater than 40%
You will not qualify if you...
- Preoperative atrial fibrillation
- Previous history of interventionally treated arrhythmias
- Second and third degree atrioventricular block
- Bradycardia with heart rate 450/min
- Pacemaker
- Renal or hepatic insufficiency
- Emergency procedures
- History of serious mental illness, delirium, and severe dementia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Cardiovascular Diseases of Vojvodina
Kamenitz, Serbia, 21204
Actively Recruiting
Research Team
M
Mihaela Preveden, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here